Company intelligence
BioLight Labs
Advancing the Future of Mitochondrial Wellness
Biotechnology Research
2 employees
3 public signals
Verified activity
Signals from BioLight Labs
3 published signals
Research & Knowledge
BioLight Labs published new research in Nature showing that late-life semaglutide extended lifespan in female mice by approximately 12% while improving markers of healthspan.
Reported by Mike Belkowski
Research & Knowledge
BioLight Labs published a new 2026 systematic review finding that photodynamic therapy with photosensitizers like methylene blue can help reduce microbial load, while photobiomodulation supports mitochondrial activity, pain reduction, inflammation control, and tissue healing.
Reported by Mike Belkowski
Research & Knowledge
BioLight Labs published a 2026 review highlighting Thymosin Alpha-1's potential to support T cells, natural killer cells, dendritic cells, and immune infiltration into cold tumors alongside chemotherapy, radiation, and immunotherapy.
Reported by Mike Belkowski